cabozantinib,nivolumab
exelixis,bms
['nivo', 'nivolumab', 'cabozantinib', 'renal,(-adrenal)']
#asco22 #nivolumabcabozantinib associated with greater proportion of deep objective responses for advanced #renalcellcarcinoma 